harvestiro, Author at Global Clinical Research Organization

Blogs

Data Governance and Geopolitics: The New Operational Reality of Global Clinical Trials

Part 4 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…

harvestiroSeptember 11, 2026

HiRO Updates

HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulation

HiRO and Differentia have signed a Memorandum of Understanding establishing a framework for joint development…

harvestiroSeptember 1, 2026

Blogs

Asia’s Shifting Regulatory Map: What Sponsors Need to Know Before Choosing a Trial Location

Part 3 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…

harvestiroAugust 26, 2026

Blogs

The HiRO Growth Story: Creating a Global CRO Through Strategic Growth

Part 2 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…

harvestiroAugust 11, 2026

HiRO Updates

HiRO to Attend the SCDM Annual Conference 2026 in Raleigh, North Carolina

Stop by Booth #546 to Meet the HiRO Team at SCDM 2026 HiRO is excited…

harvestiroSeptember 1, 2026

Blogs

What Makes a Modern CRO? Inside HiRO’s Global Growth Story

Part 1 of 5 in our series: What Makes a Modern CRO? Inside HiRO's Global…

harvestiroAugust 26, 2026

HiRO Updates

HiRO and Monash Health Sign Site Alliance Agreement at BIO Asia-Taiwan

HiRO Partners with Monash Health to Speed Up Complex Clinical Trials HiRO has formalized a…

harvestiroAugust 11, 2026

Blogs Case Studies

Glioblastoma Clinical Trials – Where Progress is Actually Happening in Glioma Research

Where Glioma Research Is Actually Moving Forward Glioblastoma (GBM) is the most common and most…

harvestiroJuly 31, 2026

HiRO Updates

HiRO to Attend the 2026 Australia & New Zealand Site Solutions Summit

HiRO is heading to Melbourne this July for the ANZ Site Solutions Summit. The event…

harvestiroJuly 13, 2026

Blogs Case Studies

Sarcoma Clinical Trials – Cell Therapy’s Solid-Tumor Breakthrough, and What It Means for a Rare Cancer

A Turning Point for Cell Therapy in Solid Tumors, and for Sarcoma For most of…

harvestiroJuly 31, 2026

harvestiro

Data Governance and Geopolitics: The New Operational Reality of Global Clinical Trials

HiRO and Differentia Biotech Forge Strategic Alliance to Redefine Clinical Trial Design Through AI-Powered Simulation

Asia’s Shifting Regulatory Map: What Sponsors Need to Know Before Choosing a Trial Location

The HiRO Growth Story: Creating a Global CRO Through Strategic Growth

HiRO to Attend the SCDM Annual Conference 2026 in Raleigh, North Carolina

What Makes a Modern CRO? Inside HiRO’s Global Growth Story

HiRO and Monash Health Sign Site Alliance Agreement at BIO Asia-Taiwan

Glioblastoma Clinical Trials – Where Progress is Actually Happening in Glioma Research

HiRO to Attend the 2026 Australia & New Zealand Site Solutions Summit

Sarcoma Clinical Trials – Cell Therapy’s Solid-Tumor Breakthrough, and What It Means for a Rare Cancer

220 Davidson Ave.
Ste. 201
Somerset, NJ 08873

202 Water Street
Ste. 201
Excelsior, MN 55331

Em. info@harvestiro.com